Soft tissue malignant neoplasms. Clinical case presentation in treatment with deuterium depleted water
Authors: Trăilă Nicola, Ioan Ştefănescu, Cristian Mladin, Radu Tamaian, Gheorghe Titescu, Răzvan Ilina
1st International Symposium on Deuterium Depletion, 2010, Budapest, Hungary
Background
Deuterium depletion water has cellular antiproliferation effects. From experimental works and from clinical experience it is accomplished that its benefit effect in the treatment of different types of cancer. In Oncological Surgery Department we gave deuterium depleted water (DDW) in two types of cancer: advanced rectosigmoidian junction cancer and soft tissue sarcomas.
There have been taken for study seven patients, with superior rectum cancer penetrating in iliac vessels. In these cases it has been administered intra-arterial chemotherapy by a catheter introduced in inferior sigmoidian artery (superior hemoroidal) and left out under the ribs through a Braun chamber. There have been performed 6 series with 5-Flourouracil and Calcium folinat. After the intestinal transit has been recovered, the DDW was given, 25 ppm, one liter per day.
To these patients has been discovered a good tolerance for chemotherapy, which we have put it on the DDW administration.We had another case in study, a 13 year girl who consumed DDW for 5 years (starting from 2005), in volume of 1 liter per day, 25 ppm. The patient has received 10 series of chemotherapy, according to the 2002 European protocol, for a juvenile rabdomiosarcoma of the scalp, on the right parietal region. After tumoral ablation the patient has been given DDW every day so far. At clinical examination and paraclinical examination there is no relapse.
Conclusions
For the patients with unrespectable rectosigmoidian cancer, we consider that DDW has decreased the side effects of chemotherapy, has contributed to life prolonging and has improved the quality of life.
For the patient with rabdomiosarcoma the effect of chemotherapy and DDW was spectacular. It is well known the gravity of such malignant tumors, and the fact that the patient is surviving 5 years after is a real success.
